Concepedia
Statistics
Publications
16
Citations
1.4K
H-Index
15
Active since
1993
Affiliations
Institute of Cancer Research(Current)
Cancer Research UK
Cyclacel Pharmaceuticals (United Kingdom)
The Honourable Society of Lincoln's Inn
Health and Safety Executive
Bernard Nutley is an author at Institute of Cancer Research specializing in pharmacology, pharmacy, and medicine.
Publications per year
1993–2011
Hormonal impact of the 17α-hydroxylase/C17,20-lyase inhibitor abiraterone acetate (CB7630) in patients with prostate cancer
Anne O’Donnell, Ian Judson, Mitch Dowsett et al. · British Journal of Cancer · 2004 · 384 citations · Full text
Medicine, Endocrinology, Pharmacology +17
Pharmacologic Characterization of a Potent Inhibitor of Class I Phosphatidylinositide 3-Kinases
Florence I. Raynaud, Suzanne A. Eccles, Paul A. Clarke et al. · Cancer Research · 2007 · 352 citations · Full text
Medicine, Oncology, Pharmacology +10
Small Molecule Antagonists of the σ-1 Receptor Cause Selective Release of the Death Program in Tumor and Self-Reliant Cells and Inhibit Tumor Growth <b> <i>in Vitro</i> </b> and <b> <i>in Vivo</i> </b>
Barbara A. Spruce, Lorna Campbell, N. McTavish et al. · Cancer Research · 2004 · 165 citations
Life Sciences, Oncology, Pharmacology +16
Preclinical pharmacokinetics and metabolism of a novel prototype DNA-PK inhibitor NU7026
Bernard Nutley, Nicola F. Smith, Angela Hayes et al. · British Journal of Cancer · 2005 · 97 citations · Full text
Medicine, Oncology, Pharmacology +17
Biological monitoring of workers occupationally exposed to organophosphorus pesticides
Bernard Nutley, John Cocker · Pesticide Science · 1993 · 66 citations
Pharmacy, Environmental Sciences, Toxicology +15
1–5 of 16